Supreme Court denies W.L. Gore in stent graft patent spat with C.R. Bard

January 15, 2013 by MassDevice staff

The U.S. Supreme Court refuses to hear an appeal from W.L. Gore & Assoc. in a patent war with C.R. Bard over stent graft technology.

C.R. Bard logo
W.L. Gore & Associates logo

The U.S. Supreme Court dashed the last hopes of W.L. Gore & Assoc. in its long-running patent war with C.R. Bard (NYSE:BCR) over vascular graft technology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.